Clinical Trial: A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07790861) titled 'A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems' on Aug. 25.

Brief Summary: The purpose of this study is to learn how well orforglipron works and how safe it is in Chinese adults with obesity or overweight and related health problems. Participation in this study will last about 53 weeks (about 1 year).

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: Orforglipron

Administered orally.

DRUG: Placebo

Administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Discl...